| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,636 |
10,467 |
$1.69M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,750 |
4,690 |
$477K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,023 |
1,988 |
$433K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
938 |
934 |
$78K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
311 |
308 |
$34K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
662 |
658 |
$32K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
514 |
416 |
$30K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
803 |
800 |
$27K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,450 |
2,387 |
$17K |
| 80053 |
Comprehensive metabolic panel |
1,719 |
1,672 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
484 |
480 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
586 |
582 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
760 |
749 |
$8K |
| 87634 |
|
112 |
112 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
322 |
314 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
743 |
726 |
$3K |
| 81003 |
|
1,468 |
1,445 |
$3K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
37 |
37 |
$3K |
| 81025 |
|
335 |
332 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
53 |
53 |
$2K |
| 80306 |
|
144 |
140 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
63 |
63 |
$1K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
240 |
225 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
26 |
26 |
$1K |
| 83605 |
|
76 |
74 |
$754.71 |
| 87807 |
|
57 |
56 |
$691.14 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
15 |
15 |
$640.08 |
| 80305 |
|
39 |
39 |
$428.19 |
| 72100 |
|
32 |
32 |
$388.16 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
21 |
18 |
$258.92 |
| 83690 |
|
30 |
30 |
$194.16 |
| 94664 |
|
12 |
12 |
$170.88 |
| 84484 |
|
14 |
13 |
$147.84 |
| 80061 |
Lipid panel |
13 |
13 |
$144.59 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13 |
12 |
$97.89 |
| G0379 |
Direct admission of patient for hospital observation care |
13 |
13 |
$97.61 |
| 82550 |
|
14 |
13 |
$81.06 |
| 85048 |
|
30 |
25 |
$54.44 |
| 82962 |
|
14 |
14 |
$38.92 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
26 |
26 |
$8.48 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
127 |
124 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
29 |
28 |
$0.00 |